The force chain distributions of different numerical samples composed of elongated ellipsoids with different particle morphologies and particle sizes before shearing and after load... حسب Yongfeng Zhu (7361045)

الموضوعات:

The tangential force between two particles with different aspect ratios and sphericities for De = 6.30 mm: (a) elastic tangential contact force; (b) viscous tangential contact forc... حسب Yongfeng Zhu (7361045)

الموضوعات:

Critical state parameters obtained from DEM simulations. حسب Yongfeng Zhu (7361045)

الموضوعات:

The tangential force between two particles with different equivalent diameters for P3: (a) elastic tangential contact force; (b) viscous tangential contact force. حسب Yongfeng Zhu (7361045)

الموضوعات:

The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in high-fat diet (HFD)/ streptozotocin (STZ) -induced diabetic kidneys. حسب Liping Bao (2936715)

الموضوعات:

The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in HK-2 cells. حسب Liping Bao (2936715)

الموضوعات:

The biochemical data and protein expression levels. حسب Liping Bao (2936715)

الموضوعات:

Effects of CGA on renal biochemical markers. حسب Liping Bao (2936715)

الموضوعات:

The effects of CGA on renal histopathological injury. حسب Liping Bao (2936715)

الموضوعات:

Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells. حسب Liping Bao (2936715)

الموضوعات:

Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. حسب Rahul H. Jayaram (21463899)

الموضوعات:

Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. حسب Rahul H. Jayaram (21463899)

الموضوعات:

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. حسب Farrokh Habibzadeh (12256529)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات: